SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-012504
Filing Date
2021-03-11
Accepted
2021-03-11 16:10:00
Documents
3
Period of Report
2021-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cccc-8k_20210310.htm 8-K 41847
2 EX-99.1 cccc-ex991_15.htm EX-99.1 149267
3 GRAPHIC g1kfkxg31wgo000001.jpg GRAPHIC 10109
  Complete submission text file 0001564590-21-012504.txt   206504
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39567 | Film No.: 21733367
SIC: 2836 Biological Products, (No Diagnostic Substances)